|
|
|
|
|
sarpogrelate |
|
(¡¾)-1-{2-[2-(3-Methoxyphenyl)ethyl]phenoxy}-3-(dimethylamino)-2-propyl Hydrogene Succinate |
|
125926-17-2 |
|
is a serotonin 2A receptor antagonist and is clinically used for the cutaneous ulcer |
|
powder |
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|